Using these anti-NMT1 and anti-NMT2 mAb preparations, we initiated an immunohistochemical tissue survey of NMT1 and NMT2 protein levels in a large cohort of normal and breast cancer tissue samples and sought relationships among NMT protein levels, clinical outcomes, and pathologic features of the breast tumors. Here, NMT1 is linked to breast cancer.